Effect of Pterygium Excision on Intraocular Lens Power Calculation for Subsequent Cataract Operation

NCT ID: NCT00563667

Last Updated: 2010-07-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2003-12-31

Study Completion Date

2004-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Pterygium is known to induce with-the-rule astigmatism. Excision of pterygium will steepen the cornea and reduce corneal astigmatism. We postulate that the alteration of keratometry reading will indirectly affect the IOL power calculation in cases with concurrent pterygium and cataract. Concurrent pterygium and cataract is common in Hong Kong and other tropical regions. The effect of pterygium excision on intraocular lens power calculation is investigated.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pterygium Cataract Astigmatism

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

pterygium excision

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All cases with concomitant cataract and primary pterygium, which are indicated for surgery.

Exclusion Criteria

* Pterygium smaller than 1mm, which is not visually significant.
* Double headed pterygium
* Pterygium obscuring visual axis that preclude keratometry or autorefraction measurements.
* Previous corneal refractive surgery that alter the keratometric power of the cornea.
* Patients with medical problems that preclude staged ocular surgery, e.g. dementia, heart disease, on warfarin.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hospital Authority, Hong Kong

OTHER_GOV

Sponsor Role lead

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Lulu Cheng, Dr

Role: PRINCIPAL_INVESTIGATOR

Department of DOVS, Prince of Wales Hospital/ The Chinese University of Hong Kong

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Alice Ho Miu Ling Nethersole Hospital

Hong Kong, , China

Site Status

Hong Kong Eye Hospital

Hong Kong, , China

Site Status

Prince of Wales Hospital

Hong Kong, , China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

HARECCTR0500013

Identifier Type: -

Identifier Source: secondary_id

CRE-2003.353

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Photopic and Mesopic Multifocal IOL Performance
NCT06978556 ACTIVE_NOT_RECRUITING